Table 1 Geospatial maps of the prevalence and incidence of resistance of selected bacteria-antibacterial drug combinations will be created
From: Measuring and mapping the global burden of antimicrobial resistance
Bacteria | Antibacterial drug(s) |
|---|---|
Escherichia coli | Third-generation cephalosporins, fluoroquinolones |
Shigella species | Fluoroquinolones |
Klebsiella pneumoniae | Third-generation cephalosporins, carbapenems |
Streptococcus pneumoniae | Penicillin |
Staphylococcus aureus | Methicillin |
Salmonella Typhi and Paratyphi | Fluoroquinolones, chloramphenicol |
Non-typhoidal Salmonellae | Fluoroquinolones |
Neisseria gonorrhoeae | Third-generation cephalosporins |
Mycobacterium tuberculosis | First-line – isoniazid, rifampicin Second-line – fluoroquinolones, amikacin, capreomycin, kanamycin |